Key result
Among 45 fetuses with Ebstein's anomaly, postnatal mortality was 44.4% with monitoring alone, whereas a combination of digoxin, steroids, and maternal hyperoxygenation yielded 0% mortality in 3 cases.
Why the study?
To examine the role of echocardiography in perinatal care, analyze the impact of prenatal treatment on neonatal outcomes, and assess potential environmental risk factors in fetal Ebstein's anomaly in Poland.
Does prenatal treatment with digoxin, steroids, and/or hyperoxygenation improve postnatal mortality in fetuses with Ebstein's anomaly compared to monitoring alone?
Observational (n=45)
No
Does prenatal treatment with digoxin, steroids, and/or hyperoxygenation improve postnatal mortality in fetuses with Ebstein's anomaly compared to monitoring alone?
Answers are grounded in this paper and cite their sources.
In a single-center cohort of fetal Ebstein's anomaly, prenatal treatment strategies showed varying postnatal mortality rates, with a combination of digoxin, steroids, and hyperoxygenation yielding 0% mortality in a very small subgroup (n=3).
OBJECTIVES: To present the crucial role of echocardiographic examination in perinatal care and analyze influence of prenatal treatment for neonatal outcome. Furthermore, the attempt to answer the question if there was any relationship between the occurrence of fetal Ebstein's anomaly and environmental risk factors in polish population. METHODS: Forty-five prenatal diagnoses of Ebstein's anomaly were compiled over the 21-year period (1998‒2018) form our single unit. The analysis included the assessment of maternal parameters (age, past obstetric history, and place of residence) and fetal parameters (sex, gestational age, anatomy, the fetal cardiovascular condition assessed by the CVPS, associated extracardiac anomalies or malformations, prenatal treatment, delivery and follow-up). RESULTS: The average age of gravida was 29.5 years (± 5.2 years) and gravidae <35 years of age accounted for 80% . There were 43 singleton pregnancies and 2 cases of multiple pregnancy. Ebstein's anomaly was mostly (averagely) diagnosed at 28th week of gestation. Forty-three fetuses had normal karyotypes and two had trisomy 21. Cardiomegaly was present in 91% (41) of fetuses. The average heart area to chest area ratio was 0.56 (± 0.12). In 21 cases, there was only fetal monitoring - echocardiographic examinations and postnatal mortality was 44.4%. In 5 cases, transplacental digoxin treatment was administered and mortality was: 40%. In another 5 cases, only steroid therapy was applied and postnatal mortality was 100%. Steroids and transplacental digoxin treatment were administered in 11 cases and mortality was 63.6%. In 3 last cases transplacental digoxin treatment, steroids and maternal hyperoxygenation therapy were given and mortality was 0%. Cesarean section rate was 49%. Moreover, due to Ebstein's anomaly regional peak of occurrence benzopyrene was deliberated as environmental risk factor. CONCLUSIONS: Fetal Ebstein's anomaly occurred in our population in healthy young women, expecting their first child and malformation was not related to fetus gender, nor to maternal health condition. Our data can be a new signal for the development of novel treatment strategies in therapy in fetuses with Ebstein's anomaly.
No takes yet. Share an insight, caveat, or question.
Rydzewska et al. (2020) conducted an observational in Fetal Ebstein's anomaly (n=45). Prenatal medical treatment (digoxin, steroids, hyperoxygenation) vs. Fetal monitoring only was evaluated on Postnatal mortality. Among 45 fetuses with Ebstein's anomaly, postnatal mortality was 44.4% with monitoring alone, whereas a combination of digoxin, steroids, and maternal hyperoxygenation yielded 0% mortality in 3 cases.
Synapse has enriched 10 related papers. Consider them for comparative context: